| Product NDC: | 27437-205 |
| Proprietary Name: | SUPRAX |
| Non Proprietary Name: | cefixime |
| Active Ingredient(s): | 200 mg/1 & nbsp; cefixime |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 27437-205 |
| Labeler Name: | LUPIN PHARMA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065380 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121205 |
| Package NDC: | 27437-205-08 |
| Package Description: | 50 TABLET, CHEWABLE in 1 BOTTLE (27437-205-08) |
| NDC Code | 27437-205-08 |
| Proprietary Name | SUPRAX |
| Package Description | 50 TABLET, CHEWABLE in 1 BOTTLE (27437-205-08) |
| Product NDC | 27437-205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cefixime |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20121205 |
| Marketing Category Name | ANDA |
| Labeler Name | LUPIN PHARMA |
| Substance Name | CEFIXIME |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |